The Year in Cardiology 2012: focus on cardiovascular disease prevention

Marietta Charakida1, Stefano Masi, John Eric Deanfield

  • 1National Centre for Cardiovascular Prevention and Outcomes, Institute of Cardiovascular Science, University College London, UK.

European Heart Journal
|January 4, 2013
PubMed

Insights

Cardiovascular disease (CVD) mortality has decreased, but life with disability persists. Focusing on CVD prevention, utilizing new European guidelines, biomarkers, and advanced imaging, can significantly reduce risks.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Advances in cardiovascular (CV) treatment reduced mortality but increased life with disability.
  • A shift towards CV prevention is crucial to counteract this trend.

Purpose of the Study:

  • To review new European guidelines on CV prevention.
  • To discuss biomarkers and vascular imaging for refined CV risk prediction.
  • To present lifestyle and pharmacological advances for CV risk reduction.

Main Methods:

  • Review of current literature and European guidelines.
  • Discussion of established and emerging biomarkers.
  • Analysis of vascular imaging techniques for risk stratification.

Main Results:

  • New European guidelines offer a framework for CV prevention.
  • Biomarkers and vascular imaging enhance CV risk prediction accuracy.
  • Lifestyle modifications and pharmacological interventions show significant potential for risk reduction.

Conclusions:

  • Implementing updated CV prevention strategies is essential.
  • Personalized risk assessment using biomarkers and imaging is key.
  • Integrated approaches combining lifestyle and pharmacotherapy will improve CV outcomes.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...